D. Rowley

R. Wissler, D. Rowley, E. Benditt, 1949, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Homeostasis of the antibody response: immunoregulation by NK cells.

L. Abruzzo, D. Rowley, Lynne V. Abruzzo, 1983, Science.

Cancer immunotherapy and preclinical studies: why we are not wasting our time with animal experiments.

G. Riethmüller, H. Schreiber, D. Rowley, 2006, Hematology/oncology clinics of North America.

Inflammation as a tumor promoter in cancer induction.

H. Schreiber, M. Philip, D. Rowley, 2004, Seminars in cancer biology.

5-HYDROXYTRYPTAMINE AND HISTAMINE AS MEDIATORS OF THE VASCULAR INJURY PRODUCED BY AGENTS WHICH DAMAGE MAST CELLS IN RATS

D. Rowley, E. Benditt, 1956, The Journal of experimental medicine.

Antigen-Specific Bacterial Vaccine Combined with Anti-PD-L1 Rescues Dysfunctional Endogenous T Cells to Reject Long-Established Cancer

D. Munn, R. Hoffman, B. Engels, 2013, Cancer Immunology Research.

Bystander elimination of antigen loss variants in established tumors

H. Schreiber, M. Spiotto, D. Rowley, 2004, Nature Medicine.

The immunological meaning of Thy-1-negative NK cells.

D. Rowley, P. Shah, 1986, Immunology today.

Relapse or eradication of cancer is predicted by peptide-major histocompatibility complex affinity.

John Sidney, Alessandro Sette, David M Kranz, 2013, Cancer cell.

The pattern of gene expression in mouse Gr-1(+) myeloid progenitor cells.

J. Rowley, T. Clark, S. Lee, 2001, Genomics.

HOMEOSTASIS OF ANTIBODY FORMATION IN THE ADULT RAT

F. Fitch, D. Rowley, 1964, The Journal of experimental medicine.

Targeting stroma to treat cancers.

B. Engels, H. Schreiber, D. Rowley, 2012, Seminars in cancer biology.

Histologic Localization of Hemolysin-Containing Cells

F. Fitch, D. Rowley, R. Stejskal, 1969 .

IFN-gamma- and TNF-dependent bystander eradication of antigen-loss variants in established mouse cancers.

Bin Zhang, H. Schreiber, T. Karrison, 2008, The Journal of clinical investigation.

Equilibrium between host and cancer caused by effector T cells killing tumor stroma.

D. Kranz, Bin Zhang, H. Schreiber, 2008, Cancer research.

Antibody against the antigen receptor of a plasmacytoma prolongs survival of mice bearing the tumor.

P. Beatty, D. Rowley, B. S. Kim, 1976, Journal of immunology.

The role of stroma in immune recognition and destruction of well-established solid tumors.

H. Schreiber, yang-xin fu, D. Rowley, 2006, Current opinion in immunology.

Role of TGF‐β in immune‐evasion of cancer

H. Schreiber, D. Rowley, C. Beck, 2001 .

Antagonism of 5-Hydroxytryptamine by Chlorpromazine

D. Rowley, E. Benditt, 1956, Science.

Suppression by autogenous complementary idiotypes: the priority of the first response

H. Schreiber, D. Rowley, I. Lorbach, 1976, The Journal of experimental medicine.

Specific antigens inhibit plasmacytoma cells bearing phosphorylcholine-binding myeloma proteins.

D. Rowley, B. S. Kim, L. Mallat, 1978, Cellular immunology.

Suppression of tumor rejection by autologous anti-idiotypic immunity.

M. Kripke, H. Schreiber, D. Rowley, 1980, Proceedings of the National Academy of Sciences of the United States of America.

An immunologic network.

D A Rowley, H Köhler, J D Cowan, 1980, Contemporary topics in immunobiology.

Hypersensitivity: Specific Immunologic Suppression of the Delayed Type

D. Rowley, M. Axelrad, 1968, Science.

Enhanced Growth of Primary Tumors in Cancer-Prone Mice after Immunization against the Mutant Region of an Inherited Oncoprotein

Christopher A. Lazarski, G. Beck-Engeser, H. Schreiber, 2000, The Journal of experimental medicine.

NK cells suppress the generation of Lyt-2+ cytolytic T cells by suppressing or eliminating dendritic cells.

D. Rowley, P. Shah, S. Gilbertson, 1986, Journal of immunology.

Increasing tumor antigen expression overcomes "ignorance" to solid tumors via crosspresentation by bone marrow-derived stromal cells.

M. Nishimura, H. Schreiber, yang-xin fu, 2002, Immunity.

Role of TGF-beta in immune-evasion of cancer.

H. Schreiber, D. Rowley, C. Beck, 2001, Microscopy research and technique.

Tumor Stroma and the Antitumor Immune Response

Bin Zhang, H. Schreiber, D. Rowley, 2008 .

THE SPECIFIC SELECTION OF RECIRCULATING LYMPHOCYTES BY ANTIGEN IN NORMAL AND PREIMMUNIZED RATS

R. Atkins, J. Gowans, D. Rowley, 1972, The Journal of experimental medicine.

A comparison of murine hepatic accessory cells and splenic dendritic cells.

D. Rowley, P. Shah, D. Magilavy, 1989, Cellular immunology.

Induced sensitization of tumor stroma leads to eradication of established cancer by T cells

R. Weichselbaum, D. Kranz, Bin Zhang, 2007, The Journal of experimental medicine.

CELLULAR AND HUMORAL IMMUNITY AFTER ALLOGENEIC TRANSPLANTATION IN THE RAT II. COMPARISON OF A 51Cr RELEASE ASSAY AND MODIFIED MICROCYTOTOXICITY ASSAY FOR DETECTION OF CELLULAR IMMUNITY AND BLOCKING SERUM FACTORS

D. Scollard, F. Fitch, F. Stuart, 1973, Transplantation.

CELLULAR AND HUMORAL IMMUNITY AFTER ALLOGENEIC TRANSPLANTATION IN THE RAT III. THE EFFECT OF PASSIVE ANTIBODY ON CELLULAR AND HUMORAL IMMUNITY AFTER ALLOGENEIC RENAL TRANSPLANTATION

F. Fitch, F. Stuart, D. Rowley, 1973, Transplantation.

CD4+ AND B LYMPHOCYTES IN TRANSPLANTATION IMMUNITY: II. AUGMENTED REJECTION OF TUMOR ALLOGRAFTS BY MICE LACKING B CELLS

H. Schreiber, D. Rowley, Paul A. Moach, 1993, Transplantation.

THE MECHANISM OF TOLERANCE PRODUCED IN RATS TO SHEEP ERYTHROCYTES. II. THE PLAQUE-FORMING CELL AND ANTIBODY RESPONSE TO MULTIPLE INJECTIONS OF ANTIGEN BEGUN AT BIRTH.

F. Fitch, D. Rowley, 1965, The Journal of experimental medicine.

THE MECHANISM OF TOLERANCE PRODUCED IN RATS TO SHEEP ERYTHROCYTES

F. Fitch, D. Rowley, 1965, The Journal of experimental medicine.

Stroma is critical for preventing or permitting immunological destruction of antigenic cancer cells

H. Schreiber, Sunanda R Singh, D. Rowley, 1992, The Journal of experimental medicine.

Targeting mutations predictably.

J. Rowley, D. Rowley, Hans M Schreiber, 2011, Blood.

A systematic analysis of experimental immunotherapies on tumors differing in size and duration of growth

Ronald A. Thisted, Hans Schreiber, R. Thisted, 2012, Oncoimmunology.

Progression of cancer from indolent to aggressive despite antigen retention and increased expression of interferon-gamma inducible genes.

R. Weichselbaum, N. Khodarev, H. Schreiber, 2011, Cancer immunity.

A first or dominant immunization. I. Suppression of simultaneous cytolytic T cell responses to unrelated alloantigens

D. Rowley, R. Stach, Ren~e M Stach, 1993, The Journal of experimental medicine.

Immunological enhancement of primary tumor development and its prevention.

H. Schreiber, D. Rowley, T. Wu, 2000, Seminars in cancer biology.

Major Histocompatibility Complex Class I and Unique Antigen Expression by Murine Tumors That Escaped from CD8+ T-Cell-dependent Surveillance1 Analysis of Class Antigens. The

H. Schreiber, P. Ward, D. Rowley, 2006 .

Major Histocompatibility Complex Class I and Unique Antigen Expression by Murine Tumors That Escaped from CD 8 + T-Cell-dependent Surveillance 1

H. Schreiber, P. Ward, D. Rowley, 2006 .

Multiple cancers. Tumor burden permits the outgrowth of other cancers

C. Van Waes, C. Waes, H. Schreiber, 1985, The Journal of experimental medicine.

B lymphocytes secreting IgG linked to latent transforming growth factor-beta prevent primary cytolytic T lymphocyte responses.

D. Rowley, R. Stach, 1998, International immunology.

Immune response to phosphorylcholine. III. Requirement of the Fc portion and equal effectiveness of IgG subclasses in anti-receptor antibody-induced suppression.

B. Richardson, D. Rowley, S. Smyk, 1977, Journal of immunology.

Awakening Immunity

Hans Schreiber, H. Schreiber, D. Rowley, 2010, Science.

A first or dominant immunization. II. Induced immunoglobulin carries transforming growth factor beta and suppresses cytolytic T cell responses to unrelated alloantigens

D. Rowley, R. Stach, Ren~e M Stach, 1993, The Journal of experimental medicine.

Cytokines as effectors in tumor immunity

H. Schreiber, J. Rothstein, M. Teng, 1990 .

SEVERE ACTIVE CUTANEOUS HYPERSENSITIVITY IN THE RAT PRODUCED BY HEMOPHILUS PERTUSSIS VACCINE

D. Rowley, J. Chutkow, C. Attig, 1959, The Journal of experimental medicine.

SEVERE ACTIVE CUTANEOUS HYPERSENSITIVITY IN T H E RAT PRODUCED BY HEMOPHILUS PERTUSSIS VACCINE* BY DONALD A. ROWLEY, M.D., JERRY CHUTKOW, M.D., AND CHARLES ATTIG

D. Rowley, J. Chutkow, C. Attig, 2003 .

THE RATE OF DIVISION OF ANTIBODY-FORMING CELLS DURING THE EARLY PRIMARY IMMUNE RESPONSE

B. Brown, D. Mosier, F. Fitch, 1968, The Journal of experimental medicine.

Presence of both cell-mediated immunity and serum-blocking factors in rat renal allografts "enhanced" by passive immunization.

K. Hellström, I. Hellström, F. Fitch, 1971, Transplantation.

The immune response suppressed by specific antibody.

F. Fitch, D. Rowley, C. Pierce, 1969, Immunology.

Do antibody-forming cells circulate in the blood?

L. Leserman, F. Fitch, D. Rowley, 1969, Journal of immunology.

The sustained suppression of hemolysin response in passively immunized rats.

F. Fitch, D. Rowley, M. Neiders, 1962, Journal of immunology.

Cell Respiration as a Requirement for Antibody Release in vitro

M. Berenbaum, F. Fitch, D. Rowley, 1968, Nature.

Ultrastructure of Antibody-forming Cells

F. Fitch, D. Rowley, S. Coulthard, 1965, Nature.

Time-dependent resistance or susceptibility of tumor cells to cytotoxic antibody after exposure to a chemotherapeutic agent.

M. Loken, H. Schreiber, P. Leibson, 1978, Proceedings of the National Academy of Sciences of the United States of America.

THE RATE OF DIVISION OF ANTIBODY-FORMING CELLS DURING THE EARLY PRIMARY IMMUNE RESPONSE

B. Brown, D. Mosier, F. Fitch, 1968, The Journal of experimental medicine.

Regulation by complementary idiotypes. Ig protects the clone producing it

P. Griffith, D. Rowley, I. Lorbach, 1981, The Journal of experimental medicine.

The concept of regulation through complementary idiotypes in an immunologic network includes two essential ideas: (a) complementary responses may be stimulated by a single epitope because the specific products of the idiotypic and anti-idiotypic

P. Griffith, D. Rowley, 2003 .